These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 14502137)

  • 1. Comparative study of microfibrillar collagen hemostat (Colgel) and oxidized cellulose (Surgicel) in high transfusion-risk cardiac surgery.
    Sirlak M; Eryilmaz S; Yazicioglu L; Kiziltepe U; Eyileten Z; Durdu MS; Tasoz R; Eren NT; Aral A; Kaya B; Akalin H
    J Thorac Cardiovasc Surg; 2003 Sep; 126(3):666-70. PubMed ID: 14502137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Hemostatic Effectiveness of SURGICEL® Powder in Mild and Moderate Intraoperative Bleeding.
    Al-Attar N; de Jonge E; Kocharian R; Ilie B; Barnett E; Berrevoet F
    Clin Appl Thromb Hemost; 2023; 29():10760296231190376. PubMed ID: 37501509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Real-World Utilization Pattern of Increased Utilization of Advanced Topical Adjunctive Hemostats in a Vertically Integrated Healthcare System.
    Stern L; Lee YC; Tao B; Lamerato L; Gangoli G; Kocharian R; Danker Iii W
    J Health Econ Outcomes Res; 2017; 4(2):103-112. PubMed ID: 37661947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SURGICEL mimicking a recurrence of a temporomandibular joint chondrosarcoma.
    Azami Hassani FE; Slimani F
    Ann Med Surg (Lond); 2021 Mar; 63():102187. PubMed ID: 33717476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the use of Surgicel affect postsurgical radiological follow-up of kidney tumors?
    Djafari AA; Hojjati SA; Eslami AH; Samenezhad S; Faraji S
    Radiol Case Rep; 2024 Jul; 19(7):2856-2858. PubMed ID: 38689813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model.
    Ereth MH; Schaff M; Ericson EF; Wetjen NM; Nuttall GA; Oliver WC
    Neurosurgery; 2008 Oct; 63(4 Suppl 2):369-72; discussion 372. PubMed ID: 18981845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world outcomes of hemostatic matrices in cardiac surgery.
    Tackett SM; Calcaterra D; Magee G; Lattouf OM
    J Cardiothorac Vasc Anesth; 2014 Dec; 28(6):1558-65. PubMed ID: 25245578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemostatic Role of TachoSil Surgical Patch in Cardiac Surgery.
    Alizadeh Ghavidel A; Mirmesdagh Y; Samiei N; Gholampour Dehaki M
    J Cardiovasc Thorac Res; 2014; 6(2):91-5. PubMed ID: 25031823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital economic impact from hemostatic matrix usage in cardiac surgery.
    Tackett SM; Sugarman R; Kreuwel HT; Alvarez P; Nasso G
    J Med Econ; 2014 Sep; 17(9):670-6. PubMed ID: 24927164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model.
    Lewis KM; Atlee HD; Mannone AJ; Dwyer J; Lin L; Goppelt A; Redl H
    J Invest Surg; 2013 Jun; 26(3):141-8. PubMed ID: 23514063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen hemostat significantly reduces time to hemostasis compared with cellulose: COBBANA, a single-center, randomized trial.
    Qerimi B; Baumann P; Hüsing J; Knaebel HP; Schumacher H
    Am J Surg; 2013 Jun; 205(6):636-41. PubMed ID: 23332688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta-analysis.
    Beverly A; Ong G; Kimber C; Sandercock J; Dorée C; Welton NJ; Wicks P; Estcourt LJ
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013649. PubMed ID: 36800489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered Molecular Therapeutics Targeting Fibrin and the Coagulation System: a Biophysical Perspective.
    Risser F; Urosev I; López-Morales J; Sun Y; Nash MA
    Biophys Rev; 2022 Apr; 14(2):427-461. PubMed ID: 35399372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomaterials as Haemostatic Agents in Cardiovascular Surgery: Review of Current Situation and Future Trends.
    Moldovan H; Antoniac I; Gheorghiță D; Safta MS; Preda S; Broască M; Badilă E; Fronea O; Scafa-Udrişte A; Cacoveanu M; Molnar A; Costache VS; Zaharia O
    Polymers (Basel); 2022 Mar; 14(6):. PubMed ID: 35335519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avitene™ Microfibrillar Collagen Hemostat for Adjunctive Hemostasis in Surgical Procedures: A Systematic Literature Review.
    Cziperle DJ
    Med Devices (Auckl); 2021; 14():155-163. PubMed ID: 34104007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Safety and Efficacy of a Novel Thrombin Containing Combination Hemostatic Powder Using a Historical Control.
    Bruckner BA; Spotnitz WD; Suarez E; Loebe M; Ngo U; Gillen DL; Manson RJ
    Clin Appl Thromb Hemost; 2021; 27():10760296211017238. PubMed ID: 34024165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPOT GRADE II: Clinical Validation of a New Method for Reproducibly Quantifying Surgical Wound Bleeding: Prospective, Multicenter, Multispecialty, Single-Arm Study.
    Gaizo DJD; Spotnitz WD; Hoffman RW; Hermann MC; Sher LS; Spotnitz RH; Genyk YS; Schorn IJ; Gillen DL; White BL; Miller BG; Manson RJ
    Clin Appl Thromb Hemost; 2020; 26():1076029620936340. PubMed ID: 32703005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical biomaterials to prevent post-tonsillectomy hemorrhage.
    Liu L; Rodman C; Worobetz NE; Johnson J; Elmaraghy C; Chiang T
    J Otolaryngol Head Neck Surg; 2019 Sep; 48(1):45. PubMed ID: 31492172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of fibrin glue in the surgery of cyanogenic and non-cyanogenic congenital cardiopathies: retrospective cohort study.
    Cheikh A; Ajaja MR; Rhazali H; Bouatia M; Benomar A; Slaoui A; Cherrah Y; Abouqal R; El Hassani A; Cheikhaoui Y
    BMC Cardiovasc Disord; 2019 May; 19(1):117. PubMed ID: 31096916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in hospital resource use and cost among surgical procedures using topical absorbable hemostats.
    Martyn D; Meckley LM; Miyasato G; Lim S; Riebman JB; Kocharian R; Scaife JG; Rao Y; Corral M
    Clinicoecon Outcomes Res; 2015; 7():567-74. PubMed ID: 26604807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.